BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22732518)

  • 1. Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.
    Björkholm C; Jardemark K; Marcus MM; Malmerfelt A; Nyberg S; Schilström B; Svensson TH
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):709-20. PubMed ID: 22732518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenaline reuptake inhibition enhances the antipsychotic-like effect of raclopride and potentiates D2-blockage-induced dopamine release in the medial prefrontal cortex of the rat.
    Linnér L; Wiker C; Wadenberg ML; Schalling M; Svensson TH
    Neuropsychopharmacology; 2002 Nov; 27(5):691-8. PubMed ID: 12431844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.
    Marcus MM; Jardemark K; Malmerfelt A; Björkholm C; Svensson TH
    Neuropsychopharmacology; 2010 Aug; 35(9):1952-61. PubMed ID: 20463659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
    Masana M; Bortolozzi A; Artigas F
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex.
    Pira L; Mongeau R; Pani L
    Eur J Pharmacol; 2004 Nov; 504(1-2):61-4. PubMed ID: 15507222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.
    Nyberg S; Jucaite A; Takano A; Kågedal M; Cselényi Z; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2235-44. PubMed ID: 23809226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
    Hertel P; Fagerquist MV; Svensson TH
    Science; 1999 Oct; 286(5437):105-7. PubMed ID: 10506554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
    Linnér L; Endersz H; Ohman D; Bengtsson F; Schalling M; Svensson TH
    J Pharmacol Exp Ther; 2001 May; 297(2):540-6. PubMed ID: 11303041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
    Wadenberg ML; Wiker C; Svensson TH
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reboxetine-induced increase of accumbal dopamine efflux is inhibited by l-propranolol: a microdialysis study with freely moving rats.
    Mizoguchi N; Saigusa T; Aono Y; Sekino R; Takada K; Oi Y; Ueda K; Koshikawa N; Cools AR
    Eur J Pharmacol; 2008 Dec; 601(1-3):94-8. PubMed ID: 18996113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
    Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
    Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine.
    Jardemark KE; Konradsson A; Schilström B; Marcus MM; Svensson TH
    Synapse; 2009 Oct; 63(10):913-20. PubMed ID: 19582782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex.
    Carboni E; Silvagni A; Vacca C; Di Chiara G
    J Neurochem; 2006 Jan; 96(2):473-81. PubMed ID: 16336224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Positron Emission Tomography Study of Norepinephrine Transporter Occupancy and Its Correlation with Symptom Response in Depressed Patients Treated with Quetiapine XR.
    Yatham LN; Sossi V; Ding YS; Vafai N; Arumugham SS; Dhanoa T; Lam RW; Bond DJ; Puyat JH
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):108-113. PubMed ID: 29016993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models.
    Cross AJ; Widzowski D; Maciag C; Zacco A; Hudzik T; Liu J; Nyberg S; Wood MW
    Br J Pharmacol; 2016 Jan; 173(1):155-66. PubMed ID: 26436896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex.
    Jardemark K; Marcus MM; Konradsson A; Svensson TH
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):157-62. PubMed ID: 15469665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine in the hippocampus is cleared by the norepinephrine transporter.
    Borgkvist A; Malmlöf T; Feltmann K; Lindskog M; Schilström B
    Int J Neuropsychopharmacol; 2012 May; 15(4):531-40. PubMed ID: 21669025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
    Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
    Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.